Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01676259
Title A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer (PROTACT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Silenseed Ltd
Indications

pancreatic cancer

Therapies

Gemcitabine + Nab-paclitaxel + siG12D-LODER

Gemcitabine + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.